Vivodyne
Brisbane, US · Founded 2020 · Delaware corporation · 38 employees on LinkedIn · 5 known investors
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.
Founders & leadership
Vivodyne was founded in 2020 by Andrei Georgescu, Dongeun Huh, and Andrei Georgescu, Ph.D..
AG
Andrei GeorgescuCo-founder
DH
Dongeun HuhCo-founder
AG
Andrei Georgescu, Ph.D.inCo-founder · Chief Executive Officer
Board
QS
Quinten StevensBoard director
AA
Alex AndrianopolousBoard director
AM
AA
JO
Julie O'ShaughnessyBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$79.7M disclosed across 2 rounds · 2021–2025
▶$77.7MraisedJun 2025 · 18 investors · Other TechnologyRule 506(b)
▶$77.7MraisedJun 2025 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Julie O'ShaughnessyDirector
- Andrei GeorgescuExecutive Officer, Director
- Quinten StevensDirector
- Alex AndrianopolousDirector
- Dongeun HuhExecutive Officer, Director
- Alex MorganDirector
- Offering amount
- $77.7M
- Amount sold
- $77.7M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedMar 2021 · 1 investors · Other TechnologyRule 506(b)
▶$2MraisedMar 2021 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ANDREI GEORGESCUExecutive Officer, Director
- DONGEUN HUHExecutive Officer, Director
- ALEX ANDRIANOPOULOSDirector
- Offering amount
- $4M
- Amount sold
- $2M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Verdiva Bio13 shared keywordsVerdiva Bio is a biotech company developing next-generation medicines for obesity, cardiometabolic diseases, and related metabolic conditions, focused on more convenient patient-friendly treatments. Its pipeline centers on rationally engineered peptides, including VRB-101 (an oral GLP-1 analog in Phase 2) and a portfolio of oral and injectable amylin-based candidates.
Vividion Therapeutics12 shared keywordsVividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins. The company operates across the full drug development spectrum from discovery to clinical development.
Molecular Devices10 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.
Viridian Therapeutics10 shared keywordsViridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
Nuvation Bio9 shared keywordsNuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.
Companies competing with Vivodyne for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vivodyne do?
- Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.
- Who founded Vivodyne?
- Vivodyne was founded by Andrei Georgescu, Dongeun Huh, Andrei Georgescu, Ph.D. in 2020.
- Who are Vivodyne's investors?
- Vivodyne's investors include Bison Ventures, Kairos Venture Investments, Llc, Khosla Ventures, Fortius Ventures, MBX Capital.
- How much funding has Vivodyne raised?
- Vivodyne has disclosed $79.7M raised across 2 rounds.
- Where is Vivodyne headquartered?
- Vivodyne is headquartered in Brisbane, US.